Purpose: To explore patterns of antimuscarinic medication as a risk factor for type 2 diabetes mellitus (T2DM). Methods: This is a retrospective cohort study of females 18 years or older within the Military Health System from 2006 to 2016. Administrative and claims data were used to select patients who initiated therapy with tolterodine, fesoterodine, oxybutynin, darifenacin, solifenacin, or trospium. Patients with no documented history of T2DM were followed for the occurrence of T2DM, the end of the study or loss of eligibility. Rates of T2DM were calculated for the overall population, by duration of therapy and by individual drugs. Crude and adjusted Cox proportional hazards were calculated to assess differences by duration of use and specific muscarinic antagonist. Results: Over 2.6 million antimuscarinic prescriptions were dispensed to 241 829 females (mean age/SD, 62 ± 18 years). Patients exposed to M 3 selective antagonists had highest risk of developing T2DM compared to those exposed to nonselective antagonists. Using oxybutynin, a nonselective antagonist as a comparator, adjusted rate ratios of T2DM were 57% (HR 1.57, 95%CI 1.48-1.67) and 29% (HR 1.29, 95%CI 1.24-1.35) significantly higher for darifenacin and solifenacin, respectively (both M 3 selective). Conclusions: We found exposure to M 3 selective antagonists darifenacin and solifenacin had the highest risk of developing T2DM compared to nonselective antagonist oxybutynin. This is supported by well described physiologic mechanisms and may allow for more informed prescribing decisions, particularly if minimizing risk of T2DM is a priority. K E Y W O R D S darifenacin, diabetes mellitus type 2, muscarinic antagonists, oxybutynin, pharmacoepidemiology, tolterodine 1 | INTRODUCTION Urinary Incontinence (UI) as defined by the International Continence Society is the involuntary loss of urine for any reason 1 and is generally classified into three subtypes to include stress UI, urge UI, and mixed UI. 2 UI is estimated to affect 25% to 50% of all adult women in the United States, 3 twice the amount of men, and is shown to increase in prevalence with age regardless of gender. 4 Moreover, recent
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.